FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894613900> ?p ?o ?g. }

• W2894613900 endingPage "138" @default.
• W2894613900 startingPage "126" @default.
• W2894613900 abstract "IntroductionNew treatments to inhibit neointimal formation after percutaneous transluminal angioplasty (PTA) are needed for patients undergoing chronic hemodialysis (HD). We compared the efficacy and safety of AMG0102, a balloon catheter containing nuclear factor κB (NF-κB) decoy oligodeoxynucleotide (ODN) with the PTA balloon catheter (control group) for arteriovenous fistula (AVF) stenosis.MethodsIn total, 175 patients (age ≥20 years, undergoing HD, with venous stenosis at the anastomotic region) were registered in this prospective open-label, randomized study. Patients were followed postoperatively for 36 weeks. The duration of primary patency on the targeted venous stenosis site (primary endpoint) was estimated by the Kaplan–Meier method.ResultsA lower restenosis risk was observed for the AMG0102 group, but it was not statistically significant (stratified log-rank test P = 0.250, hazard ratio [HR] 0.774; 95% confidence interval [CI]: 0.500–1.198). The median duration of primary patency was 245 days and 172 days in the AMG0102 and control groups, respectively. After stratification based on the status of diabetes complications, the HR was 0.666 (95% CI: 0.366–1.212; P = 0.183) and the median duration of primary patency was prolonged by 108 days in the AMG0102 group with diabetes complications (245 days) compared with the control group (137 days). Adverse event (AE) incidence up to 36 postoperative weeks did not differ between groups. Four device failures occurred in 3 patients (AMG0102 group), but none resulted in AEs.ConclusionFurther modifications to enhance NF-κB decoy ODN uptake and efficacy are necessary to show its clinical utility for AVF stenosis in chronic HD. New treatments to inhibit neointimal formation after percutaneous transluminal angioplasty (PTA) are needed for patients undergoing chronic hemodialysis (HD). We compared the efficacy and safety of AMG0102, a balloon catheter containing nuclear factor κB (NF-κB) decoy oligodeoxynucleotide (ODN) with the PTA balloon catheter (control group) for arteriovenous fistula (AVF) stenosis. In total, 175 patients (age ≥20 years, undergoing HD, with venous stenosis at the anastomotic region) were registered in this prospective open-label, randomized study. Patients were followed postoperatively for 36 weeks. The duration of primary patency on the targeted venous stenosis site (primary endpoint) was estimated by the Kaplan–Meier method. A lower restenosis risk was observed for the AMG0102 group, but it was not statistically significant (stratified log-rank test P = 0.250, hazard ratio [HR] 0.774; 95% confidence interval [CI]: 0.500–1.198). The median duration of primary patency was 245 days and 172 days in the AMG0102 and control groups, respectively. After stratification based on the status of diabetes complications, the HR was 0.666 (95% CI: 0.366–1.212; P = 0.183) and the median duration of primary patency was prolonged by 108 days in the AMG0102 group with diabetes complications (245 days) compared with the control group (137 days). Adverse event (AE) incidence up to 36 postoperative weeks did not differ between groups. Four device failures occurred in 3 patients (AMG0102 group), but none resulted in AEs. Further modifications to enhance NF-κB decoy ODN uptake and efficacy are necessary to show its clinical utility for AVF stenosis in chronic HD." @default.
• W2894613900 created "2018-10-12" @default.
• W2894613900 creator A5019042345 @default.
• W2894613900 creator A5023883550 @default.
• W2894613900 creator A5025005882 @default.
• W2894613900 creator A5052154025 @default.
• W2894613900 creator A5057999309 @default.
• W2894613900 creator A5063773353 @default.
• W2894613900 creator A5066900268 @default.
• W2894613900 date "2019-01-01" @default.
• W2894613900 modified "2023-09-23" @default.
• W2894613900 title "NF-κB Decoy Oligodeoxynucleotide-Coated Balloon Catheter for Arteriovenous Fistula in Hemodialysis" @default.
• W2894613900 cites W1973427430 @default.
• W2894613900 cites W1985184104 @default.
• W2894613900 cites W2012861732 @default.
• W2894613900 cites W2018620079 @default.
• W2894613900 cites W2022331738 @default.
• W2894613900 cites W2027835440 @default.
• W2894613900 cites W2047838071 @default.
• W2894613900 cites W2099604082 @default.
• W2894613900 cites W2108281918 @default.
• W2894613900 cites W2138928713 @default.
• W2894613900 cites W2148042420 @default.
• W2894613900 cites W2218561950 @default.
• W2894613900 cites W2272233471 @default.
• W2894613900 cites W2414963831 @default.
• W2894613900 cites W2597209621 @default.
• W2894613900 cites W2999065750 @default.
• W2894613900 cites W4294571461 @default.
• W2894613900 doi "https://doi.org/10.1016/j.ekir.2018.09.016" @default.
• W2894613900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6308821" @default.
• W2894613900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30596176" @default.
• W2894613900 hasPublicationYear "2019" @default.
• W2894613900 type Work @default.
• W2894613900 sameAs 2894613900 @default.
• W2894613900 citedByCount "4" @default.
• W2894613900 countsByYear W28946139002019 @default.
• W2894613900 countsByYear W28946139002020 @default.
• W2894613900 countsByYear W28946139002021 @default.
• W2894613900 crossrefType "journal-article" @default.
• W2894613900 hasAuthorship W2894613900A5019042345 @default.
• W2894613900 hasAuthorship W2894613900A5023883550 @default.
• W2894613900 hasAuthorship W2894613900A5025005882 @default.
• W2894613900 hasAuthorship W2894613900A5052154025 @default.
• W2894613900 hasAuthorship W2894613900A5057999309 @default.
• W2894613900 hasAuthorship W2894613900A5063773353 @default.
• W2894613900 hasAuthorship W2894613900A5066900268 @default.
• W2894613900 hasBestOaLocation W28946139001 @default.
• W2894613900 hasConcept C126322002 @default.
• W2894613900 hasConcept C126894567 @default.
• W2894613900 hasConcept C141071460 @default.
• W2894613900 hasConcept C168563851 @default.
• W2894613900 hasConcept C197934379 @default.
• W2894613900 hasConcept C203092338 @default.
• W2894613900 hasConcept C207103383 @default.
• W2894613900 hasConcept C2776341189 @default.
• W2894613900 hasConcept C2778063415 @default.
• W2894613900 hasConcept C2778269268 @default.
• W2894613900 hasConcept C2778283817 @default.
• W2894613900 hasConcept C2778583881 @default.
• W2894613900 hasConcept C2779063477 @default.
• W2894613900 hasConcept C2780007028 @default.
• W2894613900 hasConcept C2780326628 @default.
• W2894613900 hasConcept C2780868729 @default.
• W2894613900 hasConcept C2781267111 @default.
• W2894613900 hasConcept C44249647 @default.
• W2894613900 hasConcept C71924100 @default.
• W2894613900 hasConceptScore W2894613900C126322002 @default.
• W2894613900 hasConceptScore W2894613900C126894567 @default.
• W2894613900 hasConceptScore W2894613900C141071460 @default.
• W2894613900 hasConceptScore W2894613900C168563851 @default.
• W2894613900 hasConceptScore W2894613900C197934379 @default.
• W2894613900 hasConceptScore W2894613900C203092338 @default.
• W2894613900 hasConceptScore W2894613900C207103383 @default.
• W2894613900 hasConceptScore W2894613900C2776341189 @default.
• W2894613900 hasConceptScore W2894613900C2778063415 @default.
• W2894613900 hasConceptScore W2894613900C2778269268 @default.
• W2894613900 hasConceptScore W2894613900C2778283817 @default.
• W2894613900 hasConceptScore W2894613900C2778583881 @default.
• W2894613900 hasConceptScore W2894613900C2779063477 @default.
• W2894613900 hasConceptScore W2894613900C2780007028 @default.
• W2894613900 hasConceptScore W2894613900C2780326628 @default.
• W2894613900 hasConceptScore W2894613900C2780868729 @default.
• W2894613900 hasConceptScore W2894613900C2781267111 @default.
• W2894613900 hasConceptScore W2894613900C44249647 @default.
• W2894613900 hasConceptScore W2894613900C71924100 @default.
• W2894613900 hasIssue "1" @default.
• W2894613900 hasLocation W28946139001 @default.
• W2894613900 hasLocation W28946139002 @default.
• W2894613900 hasLocation W28946139003 @default.
• W2894613900 hasLocation W28946139004 @default.
• W2894613900 hasOpenAccess W2894613900 @default.
• W2894613900 hasPrimaryLocation W28946139001 @default.
• W2894613900 hasRelatedWork W113810927 @default.
• W2894613900 hasRelatedWork W1993239454 @default.
• W2894613900 hasRelatedWork W2096161652 @default.
• W2894613900 hasRelatedWork W2514950077 @default.
• W2894613900 hasRelatedWork W3023043385 @default.

• next